Emerging as a significant breakthrough in the battle against obesity, the drug is attracting considerable attention . This treatment combines the action of two established GLP-1 receptor agonists, dulaglutide , plus an unique glucose-dependent peptide component. Early study findings have shown significant body reduction in people with a high BMI… Read More